Driving Under Low-contrast Visibility Conditions in Parkinson Disease
Affiliations
Objective: To assess driving performance in Parkinson disease (PD) under low-contrast visibility conditions.
Methods: Licensed, active drivers with mild to moderate PD (n = 67, aged 66.2 +/- 9.0 years, median Hoehn-Yahr stage = 2) and controls (n = 51, aged 64.0 +/- 7.2 years) drove in a driving simulator under high- (clear sky) and low-contrast visibility (fog) conditions, leading up to an intersection where an incurring vehicle posed a crash risk in fog.
Results: Drivers with PD had higher SD of lateral position (SDLP) and lane violation counts (LVC) than controls during fog (p < 0.001). Transition from high- to low-contrast visibility condition increased SDLP and LVC more in PD than in controls (p < 0.01). A larger proportion of drivers with PD crashed at the intersection in fog (76.1% vs 37.3%, p < 0.0001). The time to first reaction in response to incursion was longer in drivers with PD compared with controls (median 2.5 vs 2.0 seconds, p < 0.0001). Within the PD group, the strongest predictors of poor driving outcomes under low-contrast visibility conditions were worse scores on measures of visual processing speed and attention, motion perception, contrast sensitivity, visuospatial construction, motor speed, and activities of daily living score.
Conclusions: During driving simulation under low-contrast visibility conditions, drivers with Parkinson disease (PD) had poorer vehicle control and were at higher risk for crashes, which were primarily predicted by decreased visual perception and cognition; motor dysfunction also contributed. Our results suggest that drivers with PD may be at risk for unsafe driving in low-contrast visibility conditions such as during fog or twilight.
Parkinson's Disease and Driving Fitness: A Systematic Review of the Existing Guidelines.
Stamatelos P, Economou A, Yannis G, Stefanis L, Papageorgiou S Mov Disord Clin Pract. 2024; 11(3):198-208.
PMID: 38164044 PMC: 10928339. DOI: 10.1002/mdc3.13942.
Does in-vehicle automation help individuals with Parkinson's disease? A preliminary analysis.
Giang W, Zheng H, Gibson B, Patel B, Ramirez-Zamora A, Winter S Front Neurol. 2023; 14:1225751.
PMID: 37900602 PMC: 10603248. DOI: 10.3389/fneur.2023.1225751.
Real-World Driving Data Indexes Dopaminergic Treatment Effects in Parkinson's Disease.
Chang J, Bhatti D, Rizzo M, Uc E, Bertoni J, Merickel J Mov Disord Clin Pract. 2023; 10(9):1324-1332.
PMID: 37772286 PMC: 10525064. DOI: 10.1002/mdc3.13803.
Driving Impairment in Movement Disorders.
Makhoul K, Jankovic J Mov Disord Clin Pract. 2023; 10(3):369-381.
PMID: 36949799 PMC: 10026316. DOI: 10.1002/mdc3.13676.
Furlanetti L, Baig Mirza A, Raslan A, Velicu M, Burford C, Akhbari M J Clin Med. 2023; 12(1).
PMID: 36614967 PMC: 9821168. DOI: 10.3390/jcm12010166.